We are live on ! Find out more
AA

AlphaMark Advisors Portfolio holdings

AUM $231M
1-Year Est. Return 19.98%
This Fund
S&P 500
This Quarter Est. Return
+6.81%
1 Year Est. Return
+19.98%
3 Year Est. Return
+26.38%
5 Year Est. Return
+72.27%
10 Year Est. Return
+180.76%
AUM
$239M
AUM Growth
+$8.32M
Cap. Flow
-$5.16M
Cap. Flow %
-2.16%
Top 10 Hldgs %
35.11%
Holding
546
New
36
Increased
93
Reduced
108
Closed
33

Top Buys

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$3.15M
2
BMY icon
Bristol-Myers Squibb
BMY
+$2.48M
3
DLTR icon
Dollar Tree
DLTR
+$1.94M
4
VTV icon
Vanguard Morningstar Value ETF
VTV
+$857K
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$833K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$4.4M
2
EOG icon
EOG Resources
EOG
+$2.91M
3
UTHR icon
United Therapeutics
UTHR
+$2.5M
4
ZBRA icon
Zebra Technologies
ZBRA
+$1.98M
5
PVH icon
PVH
PVH
+$1.43M

Sector Composition

Rank Sector Weight
1 Financials 10.55%
2 Consumer Staples 7.28%
3 Technology 6.91%
4 Consumer Discretionary 6.75%
5 Industrials 6.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CTMX icon
351
CytomX Therapeutics
CTMX
$675M
$8K ﹤0.01%
977
+440
+82% +$2.97K
DVYE icon
352
iShares Emerging Markets Dividend ETF
DVYE
$1.22B
$8K ﹤0.01%
200
– –
DXJ icon
353
WisdomTree Japan Hedged Equity Fund
DXJ
$7.08B
$8K ﹤0.01%
143
+1
+0.7% +$53
IHE icon
354
iShares US Pharmaceuticals ETF
IHE
$1.46B
$8K ﹤0.01%
150
– –
ITW icon
355
Illinois Tool Works
ITW
$82.6B
$8K ﹤0.01%
45
– –
JLL icon
356
Jones Lang LaSalle
JLL
$16.3B
$8K ﹤0.01%
48
+18
+60% +$2.83K
LHX icon
357
L3Harris
LHX
$51.6B
$8K ﹤0.01%
40
– –
MNKD icon
358
MannKind Corp
MNKD
$1.21B
$8K ﹤0.01%
6,481
– –
REMX icon
359
VanEck Rare Earth/Strategic Metals ETF
REMX
$1.95B
$8K ﹤0.01%
192
-100
-34% -$3.81K
VDC icon
360
Vanguard Consumer Staples ETF
VDC
$7.97B
$8K ﹤0.01%
50
-100
-67% -$15.7K
CRHM
361
DELISTED
CRH Medical Corporation
CRHM
$8K ﹤0.01%
2,400
– –
APD icon
362
Air Products & Chemicals
APD
$65.7B
$7K ﹤0.01%
28
– –
BF.B icon
363
Brown-Forman Class B
BF.B
$13.2B
$7K ﹤0.01%
100
– –
CDNS icon
364
Cadence Design Systems
CDNS
$93.6B
$7K ﹤0.01%
100
– –
FEX icon
365
First Trust Large Cap Core AlphaDEX Fund
FEX
$1.57B
$7K ﹤0.01%
105
– –
FIW icon
366
First Trust Water ETF
FIW
$1.85B
$7K ﹤0.01%
125
-25
-17% -$1.44K
GILD icon
367
Gilead Sciences
GILD
$162B
$7K ﹤0.01%
109
+1
+0.9% +$65
GLD icon
368
SPDR Gold Trust
GLD
$131B
$7K ﹤0.01%
50
– –
PBR icon
369
Petrobras
PBR
$125B
$7K ﹤0.01%
425
– –
PHO icon
370
Invesco Water Resources ETF
PHO
$2.01B
$7K ﹤0.01%
180
– –
TD icon
371
Toronto Dominion Bank
TD
$198B
$7K ﹤0.01%
129
– –
VFC icon
372
VF Corp
VFC
$5.63B
$7K ﹤0.01%
72
– –
INFI
373
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$7K ﹤0.01%
7,200
+3,000
+71% +$3.29K
CALA
374
DELISTED
Calithera Biosciences, Inc
CALA
$7K ﹤0.01%
59
– –
ZIXI
375
DELISTED
Zix Corporation
ZIXI
$7K ﹤0.01%
1,055
– –
13 14
15
16 17

Similar funds

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
MWS
Maxwell Wealth Strategies Pleasanton, California $245M AUM 23.39% 1-Year Est. Return
LHR
Lunate Holding RSC Al Maryah Island, Abu Dhabi, United Arab Emirates $211M AUM
HPFG
Hart & Patterson Financial Group Amherst, Massachusetts $206M AUM 7.82% 1-Year Est. Return
GWM
Gray Wealth Management Bangor, Maine $264M AUM 19.5% 1-Year Est. Return
KC
Kades & Cheifetz Berwyn, Pennsylvania $195M AUM 11.87% 1-Year Est. Return
SL
SIB LLC New York, New York $190M AUM 9.27% 1-Year Est. Return
CSWM
Cassady Schiller Wealth Management Cincinnati, Ohio $273M AUM 17.91% 1-Year Est. Return

AlphaMark Advisors's Q4 2019 Portfolio in Review

As of Q4 2019, AlphaMark Advisors held 546 positions worth $239M, up 3.6% from $231M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

AlphaMark Advisors's Q4 2019 filing shows 36 new, 93 increased, 108 reduced and 33 closed positions. Its largest new stake was Alexion Pharmaceuticals: 29,481 shares worth $3.19M. The largest sale was Celgene Corp, an estimated $4.4M.

By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 10% a quarter earlier, followed by Consumer Staples and Technology.

  • AlphaMark Advisors's largest Q4 2019 buy was Alexion Pharmaceuticals: 29,481 shares worth $3.19M.
  • AlphaMark Advisors added most to Bristol-Myers Squibb in Q4 2019, an estimated $2.48M increase.
  • AlphaMark Advisors's biggest Q4 2019 reduction was EOG Resources, cutting an estimated $2.91M.
  • AlphaMark Advisors fully exited Celgene Corp in Q4 2019, selling an estimated $4.4M.
  • AlphaMark Advisors's ten largest holdings make up 35% of its $239M portfolio in Q4 2019.
  • AlphaMark Advisors opened 36 new positions and closed 33 in Q4 2019.
  • AlphaMark Advisors's portfolio value rose 3.6% quarter-over-quarter to $239M.

Based on AlphaMark Advisors's 13F filing for Q4 2019, filed 7 Feb 2020.